Wynn R L, McFarland S A, Meyer E A, Coffman W B, Mumford R
Pharmacol Ther Dent. 1980;5(1-2):39-45.
Diazepam, oxazepam, N-methyloxazepam, nitrazepam and N-desmethyldiazepam prevented seizures in mice produced by lidocaine, mepivacaine, and prilocaine, and in rats by lidocaine when administered IP five minutes before IP local anesthetic. ED50 values for antagonism of lidocaine tremors ranged from 0.7 to 5.2 mg/kg for N-methyloxazepam and N-desmethyldiazepam respectively in mice, and 0.08 to 0.54 mg/kg for N-desmethyldiazepam and oxazepam respectively, and for antagonism of prilocaine convulsions, 0.2 to 0.6 mg/kg for N-methyloxazepam and N-desmethyldiazepam respectively. All compounds tested terminated ongoing lidocaine tremors when injected IV in mice with ED50 values ranging from 1.7 x 10(-3) to 3.0 x 10(-3) mg/kg for N-desmethyldiazepam and N-methyloxazepam respectively, N-methyloxazepam was significantly more potent after IP injection than nitrazepam, oxazepam and N-desmethyldiazepam against lidocaine in mice and more potent than N-desmethyldiazepam and oxazepam against mepivacaine; it was more potent than diazepam and oxazepam against lidocaine in rats. N-desmethyldiazepam was most potent against lidocaine in rats and lest potent in mice. There were no significant differences in ED50 values preventing prilocaine convulsions in mice or after IV injection to terminate ongoing lidocaine seizures. The presence of a methyl and hydroxyl group at position N-1 and C-3 respectively (N-methyloxazepam) was apparently responsible for the higher potency relative to some of the other compounds in preventing lidocaine and mepivacaine tremors in mice and lidocaine tremors in rats. It is concluded however that the magnitudes of differences in potencies of the compounds in antagonizing local anesthetic seizures in mice and rats were not so large as to prefer any single agent over diazepam.
地西泮、奥沙西泮、N-甲基奥沙西泮、硝西泮和N-去甲基地西泮在腹腔注射局部麻醉药前5分钟腹腔注射时,可预防利多卡因、甲哌卡因和丙胺卡因所致的小鼠惊厥,以及利多卡因所致的大鼠惊厥。在小鼠中,N-甲基奥沙西泮和N-去甲基地西泮对抗利多卡因震颤的半数有效量(ED50)值分别为0.7至5.2毫克/千克,N-去甲基地西泮和奥沙西泮分别为0.08至0.54毫克/千克;对抗丙胺卡因惊厥时,N-甲基奥沙西泮和N-去甲基地西泮的ED50值分别为0.2至0.6毫克/千克。在小鼠中静脉注射时,所有受试化合物均可终止正在进行的利多卡因震颤,N-去甲基地西泮和N-甲基奥沙西泮的ED50值分别为1.7×10⁻³至3.0×10⁻³毫克/千克。在小鼠中,N-甲基奥沙西泮腹腔注射后对抗利多卡因的效力明显强于硝西泮、奥沙西泮和N-去甲基地西泮,对抗甲哌卡因的效力强于N-去甲基地西泮和奥沙西泮;在大鼠中,其对抗利多卡因的效力强于地西泮和奥沙西泮。N-去甲基地西泮对大鼠利多卡因的作用最强,对小鼠的作用最弱。在预防小鼠丙胺卡因惊厥或静脉注射以终止正在进行的利多卡因惊厥方面,ED50值无显著差异。N-1位和C-3位分别存在甲基和羟基(N-甲基奥沙西泮)显然是其相对于其他一些化合物在预防小鼠利多卡因和甲哌卡因震颤以及大鼠利多卡因震颤方面效力更高的原因。然而,可以得出结论,这些化合物在拮抗小鼠和大鼠局部麻醉药惊厥方面的效力差异程度并不足以使任何单一药物优于地西泮。